The hidden biology of addiction and cancer
The hidden biology of addiction and cancer
ctDNA-guided chemo escalation does not improve recurrence-free survival in stage III colon cancer
Upfront modified FOLFOXIRI plus panitumumab improves OS in RAS/BRAF wild-type mCRC
Social determinants and survival outcomes in early-onset colorectal cancer in the US
Low frequency of dihydropyrimidine dehydrogenase variants in Mexican GI cancers should induce testing guideline reform
GLP-1 receptor agonists may slightly reduce risk of fourteen obesity-related cancers for diabetics
Trastuzumab deruxtecan benefit for some advanced gastric cancers
Abemaciclib potential therapeutic option for Kaposi sarcoma
Perioperative durvalumab and FLOT chemo can reduce risk of recurrence for some gastric cancers
Pro-inflammatory diets associated with worse outcomes for stage III colon cancer
Exercise programme may lower risk of recurrence and death for some colon cancer survivors
Neoadjuvant PD-1 blockade enables organ preservation in early dMMR tumours without surgery